Page last updated: 2024-08-25

bexarotene and prostaglandin d2

bexarotene has been researched along with prostaglandin d2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreeff, M; Duvic, M; Konopleva, M; Ni, X; Zhang, C1
Bissonnette, RP; Cesario, RM; Lamph, WW; Stone, J; Yen, WC1

Other Studies

2 other study(ies) available for bexarotene and prostaglandin d2

ArticleYear
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells.
    The Journal of investigative dermatology, 2004, Volume: 123, Issue:2

    Topics: Anticarcinogenic Agents; Apoptosis; Bexarotene; Cell Division; Cell Line, Tumor; Drug Synergism; Humans; Immunologic Factors; Ligands; Lymphocytes; Mycosis Fungoides; Nitric Oxide; Oleanolic Acid; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Transcription Factors

2004
Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
    Cancer letters, 2006, Aug-28, Volume: 240, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Bexarotene; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Fibrinolytic Agents; Humans; Male; Membrane Proteins; Mice; Mice, Nude; PPAR gamma; Prostaglandin D2; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazolidinediones; Transplantation, Heterologous; Tumor Cells, Cultured

2006